US Broker Ratings

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a 8.75% Potential Downside Amidst Strong Sector Position

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector, has built a robust reputation in the medical devices industry. The company, headquartered in..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring a Potential 17% Upside

Merit Medical Systems, Inc. (NASDAQ: MMSI) has emerged as a compelling investment opportunity within the healthcare sector, specifically in the medical instruments and supplies industry. Headquartered..

Alkermes plc (ALKS) Stock Analysis: A Compelling 14% Upside Potential for Investors

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, presents an intriguing case for investors...

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating the Healthcare Device Market with Robust Analyst Support

Integer Holdings Corporation (NYSE: ITGR), a key player in the medical device sector, has captured the attention of investors with its robust market presence and consistent..

Stevanato Group S.p.A. (STVN) Stock Analysis: A Healthcare Giant with a 23% Potential Upside

Stevanato Group S.p.A. (NYSE: STVN) is a notable player within the healthcare sector, specifically in medical instruments and supplies. With its headquarters in Piombino Dese, Italy,..

Biogen Inc. (BIIB) Stock Analysis: Potential 15% Upside Amidst Robust Drug Portfolio

Biogen Inc. (NASDAQ: BIIB), a heavyweight in the healthcare sector, is a key player in the drug manufacturing industry with a market capitalization of $29.99 billion...

Inspire Medical Systems (INSP) Stock Analysis: Investor Outlook Amid a 2.43% Potential Upside

In the dynamic world of healthcare, Inspire Medical Systems, Inc. (NASDAQ: INSP) stands out as a pioneering force in the medical devices industry. With a market..

Guardant Health, Inc. (GH) Stock Analysis: Impressive Revenue Growth Fuels Investor Optimism

Guardant Health, Inc. (NASDAQ: GH), a trailblazer in the field of precision oncology, continues to captivate investor interest with its remarkable 44.30% revenue growth. This substantial..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Potential 26.46% Upside as Healthcare Innovator Eyes Growth

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a frontrunner in the healthcare sector specializing in diagnostics and research, stands as a compelling investment opportunity with a market cap..

TransMedics Group, Inc. (TMDX) Stock Analysis: Healthcare Innovator with 43% Upside Potential

TransMedics Group, Inc. (NASDAQ: TMDX) stands at the forefront of revolutionizing organ transplant therapies with its innovative Organ Care System (OCS). As a commercial-stage medical technology..

TG Therapeutics, Inc. (TGTX) Stock Analysis: 31.52% Potential Upside Beckons Investors

TG Therapeutics, Inc. (NASDAQ: TGTX), a prominent player in the biotechnology sector, is drawing significant attention from investors with its innovative approach to treating B-cell mediated..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: A 120% Upside Potential Awaits Investors

Atrium Therapeutics, Inc. (NASDAQ: RNA) is drawing attention in the biotechnology sector with its focus on RNA therapeutics aimed at revolutionizing the treatment of cardiomyopathies. Despite..

Vaxcyte, Inc. (PCVX) Stock Analysis: Unpacking the 101.55% Potential Upside

Investors are turning their gaze toward Vaxcyte, Inc. (NASDAQ: PCVX), a clinical-stage biotechnology company with a vision to revolutionize the vaccine industry. Specializing in the development..

Oscar Health (OSCR) Stock Analysis: Navigating a 52.60% Revenue Growth Amidst a Challenging Valuation Landscape

Oscar Health, Inc. (OSCR), a prominent player in the United States healthcare plans industry, is making waves with its impressive revenue growth of 52.60%. However, this..

Insmed Incorporated (INSM): Analyst Consensus Suggests Nearly 99% Upside Potential for Biotechnology Innovator

In the rapidly evolving world of biotechnology, Insmed Incorporated (NASDAQ: INSM) has emerged as a noteworthy player, particularly for investors seeking exposure to companies tackling serious..

Chemed Corp (CHE) Stock Analysis: Evaluating Growth Potential with a Strong Market Position

Chemed Corp (NYSE: CHE), a leader in the healthcare sector, primarily offers hospice and palliative care services while also operating the well-known Roto-Rooter brand. With a..

Grifols, S.A. (GRFS) Stock Analysis: Exploring Its 38% Potential Upside in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS), a key player in the healthcare sector, particularly within the drug manufacturing industry, presents a compelling opportunity for investors with its substantial..

Charles River Laboratories Inte (CRL) Stock Analysis: Evaluating Growth Potential Despite Mixed Performance Metrics

Charles River Laboratories International, Inc. (NYSE: CRL) operates in the healthcare sector, focusing primarily on diagnostics and research. With a robust market capitalization of $11.2 billion,..

The Cooper Companies, Inc. (COO) Stock Analysis: Health Sector Innovator with 12.3% Upside Potential

The Cooper Companies, Inc. (NYSE: COO) is making waves in the healthcare sector, standing out in the competitive field of medical instruments and supplies. With a..

Regencell Bioscience Holdings L (RGC) Stock Analysis: Navigating Challenges in the TCM Sector

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a Hong Kong-based player in the healthcare sector, is carving a niche in the Traditional Chinese Medicine (TCM) industry. With..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds